ENTOS

entos-logo

Entos uses machine learning-technology for energy and force evaluations required for R&D labs. Its technology assists in analyzing quantum molecular simulation. The software uses mean-field-cost quantum calculations to analyze the data for the atomic representation of the molecules and can detect molecular spaces in a molecule. One of the products of the company is the Qcore Simulation Engine that assists with the molecular detection and modeling process.

#SimilarOrganizations #People #Financial #Website #More

ENTOS

Social Links:

Industry:
Artificial Intelligence Machine Learning Software

Founded:
2019-01-01

Address:
Los Angeles, California, United States

Country:
United States

Website Url:
http://www.entos.ai

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
53 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network


Similar Organizations

pateo-logo

Pateo

Pateo uses artificial intelligence to provide automobile solutions.

polyai-logo

PolyAI

PolyAI develops a machine learning platform for conversational artificial intelligence.

treeswift-logo

Treeswift

Treeswift utilizes robotic and machine learning technology to build forestry tools.

yembo-logo

Yembo

Yembo is an artificial intelligence company that uses advanced deep learning technology and understands videos just like humans do.


Current Advisors List

aaron-weiner_image

Aaron Weiner Board Member @ Entos
Board_member

nicholas-a-saccomano_image

Nicholas A. Saccomano Scientific Advisor @ Entos
Advisor
2022-02-01

jacob-vogelstein_image

Jacob Vogelstein Board Member @ Entos
Board_member

fred-manby_image

Fred Manby Board Member @ Entos
Board_member

thomas-miller_image

Thomas Miller Board Member @ Entos
Board_member

naren-gupta_image

Naren Gupta Board Member @ Entos
Board_member

Current Employees Featured

thomas-miller_image

Thomas Miller
Thomas Miller CEO @ Entos
CEO

fred-manby_image

Fred Manby
Fred Manby CTO @ Entos
CTO

Founder


fred-manby_image

Fred Manby

thomas-miller_image

Thomas Miller

Investors List

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series A - Entos

freeflow_image

FreeFlow

FreeFlow investment in Series A - Entos

nexus-ventures_image

Nexus Ventures

Nexus Ventures investment in Series A - Entos

catalio-capital-management_image

Catalio Capital Management

Catalio Capital Management investment in Series A - Entos

coatue_image

Coatue

Coatue investment in Series A - Entos

sequoia-capital_image

Sequoia Capital

Sequoia Capital investment in Series A - Entos

Official Site Inspections

http://www.entos.ai Semrush global rank: 3.34 M Semrush visits lastest month: 4.79 K

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 99.83.190.102
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Entos"

Entos Transforms Drug Discovery With AI-Powered …

Nov 9, 2021 That’s the principle San Diego-based startup Entos is applying to revolutionize drug design with an AI-powered approach that enables a thousandfold acceleration in molecular properties prediction. Drug discovery is …See details»

Entos Pharmaceuticals - Crunchbase Company Profile …

Entos develops next-generation genetic medicines using their proprietary Fusogenix proteolipid vehicle (PLV) drug delivery system. Fusogenix PLVs are formulated with FAST proteins to enable the delivery of nucleic acid into target …See details»

Entos Raises $53 Million Series A Round Led by Coatue …

Jul 14, 2021 Entos is eradicating these challenges with its cutting-edge OrbNet platform, an AI-driven drug and development process that creates a thousand-fold acceleration in molecular properties prediction ...See details»

Entos raises funds for AI drug discovery | C&EN Global Enterprise

Jul 19, 2021 Entos, a drug company specializing in artificial intelligence–based small-molecule discovery, has raised $54 million in series A financing, led by the investment firms Coatue …See details»

Entos | Company Overview & News - Forbes

Entos wants to leverage AI to cure forms of cancer. Its platform combines algorithms with the description of molecules to predict the properties of drugSee details»

Entos Nets $53 Million to Accelerate AI-Driven Therapies

Jul 14, 2021 Entos, the California-headquartered creator of a platform that utilizes artificial intelligence to design therapies, has secured $53 million in a funding round led by technology …See details»

Entos collects $53M to bring quantum tech to AI drug …

Jul 14, 2021 RELATED: Insitro raises $400M for machine learning-powered drug discovery efforts According to a paper published last year on the preprint server arXiv, Entos’ OrbNet AI aims to simulate ...See details»

Entos Raises $53 Million Series A Round Led by Coatue and Catalio

Jul 14, 2021 SAN DIEGO--(BUSINESS WIRE)-- Entos, Inc (“Entos” or “the Company”), the creator of a cutting-edge platform combining AI-driven technology and automated synthetic …See details»

How Entos’ delivery platform is realizing the untapped ... - Nature

How Entos’ delivery platform is realizing the untapped promise of genetic medicines Unique proteolipid vehicle (PLV) technology developed by Entos Pharmaceuticals is broadening the …See details»

Entos collects $53M to bring quantum tech to AI drug design

On July 14th, 2021, Fierce Biotech reported: The advent of artificial intelligence and machine learning already promises to shave months to years off of the typical drug discovery …See details»

Iambic Therapeutics - Crunchbase Company Profile & Funding

Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform. Iambic has assembled a world-class team that unites pioneering AI experts …See details»

Entos | Entos to Develop Open-Source Machine-Learning Tool for …

Nov 30, 2020 Entos Inc., a Pasadena-based startup, aims to provide tools for molecular and materials discovery, through the use of physics-based machine learning. Now, Entos has …See details»

Entos Announces Scientific Advisory Board Additions

Sep 9, 2021 Founded in 2019 and headquartered in San Diego, California, Entos is focused on disrupting therapeutic discovery with its cutting-edge platform that uses AI-driven automated …See details»

How Entos’ delivery platform is realizing the untapped promise of ...

Entos has used PLVs to develop a fridge-stable, single-shot COVID-19 booster. The DNA PLV vaccine—the first of its kind—is cheaper to make than mRNA LNPs and could provide longer …See details»

Entos Raises $53M in Series A Funding - FinSMEs

Jul 14, 2021 Entos, Inc., a San Diego, CA-based creator of a platform combining AI-driven technology and automated synthetic development to design small-molecule therapeutics, …See details»

Entos raises $54 million for AI-based drug discovery

Jul 18, 2021 Entos, a drug company specializing in artificial intelligence–based small-molecule discovery, has raised $54 million in series A financing, led by the investment firms Coatue …See details»

Entos Envision

Entos Envision is a cloud-based platform combining quantum mechanics and machine learning to help chemists predict molecular properties and discover new molecular systems.See details»

Entos | Envision is released worldwide as Wallace Derricotte joins ...

Mar 31, 2021 Anyone with a valid email address from an educational establishment will be able to sign on to envision.entos.ai and use the resource for free, from March 31, 2021. Secondly, …See details»

Qcore - Entos

Entos. Qcore. Physics-based quantum simulations. Efficiently perform a full range of electronic structure calculations and simulations; Run DFT, fast semi-empirical methods, robust …See details»

linkstock.net © 2022. All rights reserved